ID   ADAM7_HUMAN             Reviewed;         754 AA.
AC   Q9H2U9; A8K8X7; O75959; Q6PEJ6;
DT   31-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   07-APR-2021, entry version 153.
DE   RecName: Full=Disintegrin and metalloproteinase domain-containing protein 7;
DE            Short=ADAM 7;
DE   AltName: Full=Sperm maturation-related glycoprotein GP-83;
DE   Flags: Precursor;
GN   Name=ADAM7; Synonyms=GP83;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Epididymis;
RA   Lin Y.C., Lee Y.M., Sun G.H., Liu H.W.;
RT   "Expression of human ADAM7 (GP-83).";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 167-754 (ISOFORM 1).
RC   TISSUE=Epididymis;
RA   Liu H.W., Lin Y.C., Sun G.H.;
RT   "A ADAM-like cDNA sequence identified in cDNA library of human
RT   epididymis.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   TISSUE SPECIFICITY, INVOLVEMENT IN CUTANEOUS MELANOMA, VARIANTS SER-14;
RP   CYS-31; SER-36; TYR-106; PRO-173; ALA-180; TYR-243; GLU-302; ILE-359;
RP   GLU-533; LEU-593; LYS-639 AND ASN-703, AND CHARACTERIZATION OF VARIANTS
RP   TYR-243; ILE-359; LYS-639 AND ASN-703.
RX   PubMed=21618342; DOI=10.1002/humu.21477;
RA   Wei X., Moncada-Pazos A., Cal S., Soria-Valles C., Gartner J., Rudloff U.,
RA   Lin J.C., Rosenberg S.A., Lopez-Otin C., Samuels Y.;
RT   "Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and
RT   ADAM7 are often mutated in melanoma.";
RL   Hum. Mutat. 32:E2148-E2175(2011).
CC   -!- FUNCTION: May play an important role in male reproduction including
CC       sperm maturation and gonadotrope function. This is a non catalytic
CC       metalloprotease-like protein (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H2U9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2U9-2; Sequence=VSP_056602, VSP_056603;
CC   -!- TISSUE SPECIFICITY: Not detected in healthy melanocytes. Expressed in
CC       melanoma cells. {ECO:0000269|PubMed:21618342}.
CC   -!- DISEASE: Note=Has been found to be frequently mutated in melanoma.
CC       ADAM7 mutations may play a role in melanoma progression and metastasis.
CC       {ECO:0000269|PubMed:21618342}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF215824; AAG43987.1; -; mRNA.
DR   EMBL; AK292492; BAF85181.1; -; mRNA.
DR   EMBL; AC024958; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC120193; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC058037; AAH58037.1; -; mRNA.
DR   EMBL; AF090327; AAC36742.1; -; mRNA.
DR   CCDS; CCDS6045.1; -. [Q9H2U9-1]
DR   RefSeq; NP_003808.2; NM_003817.3. [Q9H2U9-1]
DR   SMR; Q9H2U9; -.
DR   BioGRID; 114292; 5.
DR   STRING; 9606.ENSP00000175238; -.
DR   MEROPS; M12.956; -.
DR   GlyGen; Q9H2U9; 6 sites.
DR   iPTMnet; Q9H2U9; -.
DR   PhosphoSitePlus; Q9H2U9; -.
DR   SwissPalm; Q9H2U9; -.
DR   BioMuta; ADAM7; -.
DR   DMDM; 296439449; -.
DR   MassIVE; Q9H2U9; -.
DR   PaxDb; Q9H2U9; -.
DR   PeptideAtlas; Q9H2U9; -.
DR   PRIDE; Q9H2U9; -.
DR   ProteomicsDB; 67078; -.
DR   ProteomicsDB; 80599; -. [Q9H2U9-1]
DR   Antibodypedia; 22842; 82 antibodies.
DR   DNASU; 8756; -.
DR   Ensembl; ENST00000175238; ENSP00000175238; ENSG00000069206. [Q9H2U9-1]
DR   Ensembl; ENST00000441335; ENSP00000393073; ENSG00000069206. [Q9H2U9-2]
DR   GeneID; 8756; -.
DR   KEGG; hsa:8756; -.
DR   UCSC; uc003xea.2; human. [Q9H2U9-1]
DR   CTD; 8756; -.
DR   DisGeNET; 8756; -.
DR   GeneCards; ADAM7; -.
DR   HGNC; HGNC:214; ADAM7.
DR   HPA; ENSG00000069206; Tissue enriched (epididymis).
DR   MIM; 607310; gene.
DR   neXtProt; NX_Q9H2U9; -.
DR   OpenTargets; ENSG00000069206; -.
DR   PharmGKB; PA24532; -.
DR   VEuPathDB; HostDB:ENSG00000069206.15; -.
DR   eggNOG; KOG3607; Eukaryota.
DR   GeneTree; ENSGT00940000161406; -.
DR   HOGENOM; CLU_1309742_0_0_1; -.
DR   InParanoid; Q9H2U9; -.
DR   OrthoDB; 162519at2759; -.
DR   PhylomeDB; Q9H2U9; -.
DR   TreeFam; TF314733; -.
DR   PathwayCommons; Q9H2U9; -.
DR   BioGRID-ORCS; 8756; 3 hits in 986 CRISPR screens.
DR   GenomeRNAi; 8756; -.
DR   Pharos; Q9H2U9; Tdark.
DR   PRO; PR:Q9H2U9; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q9H2U9; protein.
DR   Bgee; ENSG00000069206; Expressed in caput epididymis and 31 other tissues.
DR   ExpressionAtlas; Q9H2U9; baseline and differential.
DR   Genevisible; Q9H2U9; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IEA:InterPro.
DR   GO; GO:0008237; F:metallopeptidase activity; IBA:GO_Central.
DR   CDD; cd04269; ZnMc_adamalysin_II_like; 1.
DR   Gene3D; 3.40.390.10; -; 1.
DR   Gene3D; 4.10.70.10; -; 1.
DR   InterPro; IPR006586; ADAM_Cys-rich.
DR   InterPro; IPR018358; Disintegrin_CS.
DR   InterPro; IPR001762; Disintegrin_dom.
DR   InterPro; IPR036436; Disintegrin_dom_sf.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   InterPro; IPR034027; Reprolysin_adamalysin.
DR   Pfam; PF08516; ADAM_CR; 1.
DR   Pfam; PF00200; Disintegrin; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   Pfam; PF01421; Reprolysin; 1.
DR   PRINTS; PR00289; DISINTEGRIN.
DR   SMART; SM00608; ACR; 1.
DR   SMART; SM00050; DISIN; 1.
DR   SUPFAM; SSF57552; SSF57552; 1.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS00427; DISINTEGRIN_1; 1.
DR   PROSITE; PS50214; DISINTEGRIN_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; Glycoprotein; Membrane;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   PROPEP          19..176
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000029052"
FT   CHAIN           177..754
FT                   /note="Disintegrin and metalloproteinase domain-containing
FT                   protein 7"
FT                   /id="PRO_0000029053"
FT   TOPO_DOM        19..668
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        669..689
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        690..754
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          199..394
FT                   /note="Peptidase M12B"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00276"
FT   DOMAIN          402..488
FT                   /note="Disintegrin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00068"
FT   COMPBIAS        489..668
FT                   /note="Cys-rich"
FT   CARBOHYD        84
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        174
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        584
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        668
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        310..389
FT                   /evidence="ECO:0000250"
FT   DISULFID        350..373
FT                   /evidence="ECO:0000250"
FT   DISULFID        352..357
FT                   /evidence="ECO:0000250"
FT   DISULFID        460..480
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         194..210
FT                   /note="GIHDEKYVELFIVADDT -> VSTLLLSLPQMKHLLFS (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056602"
FT   VAR_SEQ         211..754
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056603"
FT   VARIANT         14
FT                   /note="P -> S (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; dbSNP:rs150319320)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066296"
FT   VARIANT         25
FT                   /note="E -> Q (in dbSNP:rs34852692)"
FT                   /id="VAR_046728"
FT   VARIANT         31
FT                   /note="R -> C (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; dbSNP:rs137990671)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066297"
FT   VARIANT         36
FT                   /note="P -> S (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; dbSNP:rs267601866)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066298"
FT   VARIANT         106
FT                   /note="H -> Y (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; dbSNP:rs267601867)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066299"
FT   VARIANT         173
FT                   /note="L -> P (detected in a melanoma cell line)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066300"
FT   VARIANT         180
FT                   /note="V -> A (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066301"
FT   VARIANT         205
FT                   /note="I -> V (in dbSNP:rs7829386)"
FT                   /id="VAR_046729"
FT   VARIANT         243
FT                   /note="H -> Y (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; does not affect cell growth but conferes
FT                   reduced cell adhesion to laminin-1)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066302"
FT   VARIANT         244
FT                   /note="V -> M (in dbSNP:rs13255694)"
FT                   /id="VAR_046730"
FT   VARIANT         302
FT                   /note="G -> E (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066303"
FT   VARIANT         359
FT                   /note="M -> I (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; does not affect cell growth but conferes
FT                   reduced cell adhesion to collagen IV; dbSNP:rs267601868)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066304"
FT   VARIANT         453
FT                   /note="I -> T (in dbSNP:rs3736281)"
FT                   /id="VAR_046731"
FT   VARIANT         533
FT                   /note="G -> E (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; dbSNP:rs867202281)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066305"
FT   VARIANT         570
FT                   /note="L -> V (in dbSNP:rs2307044)"
FT                   /id="VAR_046732"
FT   VARIANT         593
FT                   /note="F -> L (detected in a melanoma cell line)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066306"
FT   VARIANT         638
FT                   /note="N -> H (in dbSNP:rs13259668)"
FT                   /id="VAR_046733"
FT   VARIANT         639
FT                   /note="E -> K (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; does not affect cell growth but conferes
FT                   reduced cell adhesion to collagen IV and laminin-1;
FT                   increases cell migration capabilities compared to wild-
FT                   type; dbSNP:rs1034941983)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066307"
FT   VARIANT         703
FT                   /note="S -> N (in a cutaneous metastatic melanoma sample;
FT                   somatic mutation; does not affect cell growth but conferes
FT                   reduced cell adhesion to collagen IV and laminin-1;
FT                   increases cell migration capabilities compared to wild-
FT                   type)"
FT                   /evidence="ECO:0000269|PubMed:21618342"
FT                   /id="VAR_066308"
FT   VARIANT         735
FT                   /note="L -> P (in dbSNP:rs6980829)"
FT                   /id="VAR_046734"
FT   CONFLICT        95
FT                   /note="E -> G (in Ref. 1; AAG43987)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        369..370
FT                   /note="KF -> DL (in Ref. 5; AAC36742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        374
FT                   /note="S -> R (in Ref. 5; AAC36742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        518
FT                   /note="E -> D (in Ref. 1; AAG43987)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   754 AA;  85669 MW;  D9E9DF9B5812B0A7 CRC64;
     MLPGCIFLMI LLIPQVKEKF ILGVEGQQLV RPKKLPLIQK RDTGHTHDDD ILKTYEEELL
     YEIKLNRKTL VLHLLRSREF LGSNYSETFY SMKGEAFTRH PQIMDHCFYQ GSIVHEYDSA
     ASISTCNGLR GFFRINDQRY LIEPVKYSDE GEHLVFKYNL RVPYGANYSC TELNFTRKTV
     PGDNESEEDS KIKGIHDEKY VELFIVADDT VYRRNGHPHN KLRNRIWGMV NFVNMIYKTL
     NIHVTLVGIE IWTHEDKIEL YSNIETTLLR FSFWQEKILK TRKDFDHVVL LSGKWLYSHV
     QGISYPGGMC LPYYSTSIIK DLLPDTNIIA NRMAHQLGHN LGMQHDEFPC TCPSGKCVMD
     SDGSIPALKF SKCSQNQYHQ YLKDYKPTCM LNIPFPYNFH DFQFCGNKKL DEGEECDCGP
     AQECTNPCCD AHTCVLKPGF TCAEGECCES CQIKKAGSIC RPAKDECDFP EMCTGHSPAC
     PKDQFRVNGF PCKNSEGYCF MGKCPTREDQ CSELFDDEAI ESHDICYKMN TKGNKFGYCK
     NKENRFLPCE EKDVRCGKIY CTGGELSSLL GEDKTYHLKD PQKNATVKCK TIFLYHDSTD
     IGLVASGTKC GEGMVCNNGE CLNMEKVYIS TNCPSQCNEN PVDGHGLQCH CEEGQAPVAC
     EETLHVTNIT ILVVVLVLVI VGIGVLILLV RYRKCIKLKQ VQSPPTETLG VENKGYFGDE
     QQIRTEPILP EIHFLNKPAS KDSRGIADPN QSAK
//
